SCHEMBL347702

SCHEMBL347702

CCCN=Cc1ccccc1O

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 8/20 0.78
CA2 P00918 7/20 0.78
KDM4E B2RXH2 3/20 0.78
CA9 Q16790 6/20 0.72
ALDH1A1 P00352 4/20 0.52
KMT2A Q03164 3/20 0.52
CA1 P00915 1/20 0.51
SIRT2 Q8IXJ6 1/20 0.50
RAB9A P51151 3/20 0.49
HTT P42858 2/20 0.49
NPC1 O15118 2/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
MAPT P10636 4/20 0.47
GAA P10253 3/20 0.47
ALOX15 P16050 2/20 0.47
HSD17B10 Q99714 2/20 0.47
USP2 O75604 1/20 0.47
ALOX12 P18054 1/20 0.47
MEN1 O00255 2/20 0.47
HPGD P15428 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12050170 1.00 CA12 (0.78) CA12CA2KDM4ECA9ALDH1A1
SCHEMBL30408967 1.00 CA12 (0.78) CA12CA2KDM4ECA9ALDH1A1
SCHEMBL347701 1.00 CA12 (0.78) CA12CA2KDM4ECA9ALDH1A1
Ammonia Solution, Strong SCHEMBL4636250 0.98 CA12 (0.75) CA12CA2KDM4ECA9ALDH1A1
SCHEMBL348172 0.89 CA12 (0.79) CA12CA2KDM4ECA9ALDH1A1
SCHEMBL348171 0.89 CA12 (0.79) CA12CA2KDM4ECA9ALDH1A1
SCHEMBL17660178 0.89 CA12 (0.79) CA12CA2KDM4ECA9ALDH1A1
N,N'-Disalicylalethylenediamine SCHEMBL18852430 0.88 CA12 (1.00) CA12CA2KDM4ECA9ALDH1A1
N,N'-Disalicylalethylenediamine SCHEMBL29356999 0.88 CA12 (1.00) CA12CA2KDM4ECA9ALDH1A1
N,N'-Disalicylalethylenediamine SCHEMBL4290399 0.88 CA12 (1.00) CA12CA2KDM4ECA9ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120016147-A1 METHOD FOR PRODUCING AROMATIC COMPOUND POLYMER SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-01-19 US disclosed
US-8048982-B2 Method for producing aromatic compound polymer SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-11-01 US disclosed
EP-2241548-A1 Vanadium di-nuclear complex Sumitomo Chemical Company, Limited (JP) 2010-10-20 EP disclosed
EP-2241547-A1 Method for producing aromatic compound polymer Sumitomo Chemical Company, Limited (JP) 2010-10-20 EP disclosed
US-20090018309-A1 Method for Producing Aromatic Compound Polymer SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-01-15 US disclosed
EP-1767560-A1 METHOD FOR PRODUCING AROMATIC COMPOUND POLYMER Sumitomo Chemical Company, Limited (JP) 2007-03-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090018309-A1 Method for Producing Aromatic Compound Polymer PAH, MAOA, AHR CA12 1989/4885CA2 1431/4885KDM4E 1477/4885
US-20120016147-A1 METHOD FOR PRODUCING AROMATIC COMPOUND POLYMER PAH, MAOA, AHR CA12 1977/4885CA2 1450/4885KDM4E 1516/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.